The specific Bruton tyrosine kinase inhibitor acalabrutinib (ACP-196) shows favorable in vitro activity against chronic lymphocytic leukemia B cells with CD20 antibodies
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Ferrata Storti Foundation
2017-10-01
|
| Collection: | Haematologica |
| Accès en ligne: | https://haematologica.org/article/view/8235 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|